Literature DB >> 204861

Regulation of the deo operon in Escherichia coli: the double negative control of the deo operon by the cytR and deoR repressors in a DNA directed in vitro system.

P Valentin-Hansen, B A Svenningsen, A Munch-Petersen, K Hammer-Jespersen.   

Abstract

The synthesis of the four enzymes of the deo operon in Escherichia coli is known from in vivo experiments to be subject to a double negative control, exerted by the products of the cytR and deoR genes. A DNA-directed in vitro protein synthesizing system makes the deo enzymes (exemplified by thymidine phosphorylase) in agreement with in vivo results. Enzyme synthesis is stimulated by cyclic AMP and repressed by the cytR and deoR gene products. Repression by the cytR repressor is reversed by cytidine or adenosine in the presence of cyclic AMP, while repression by the deoR repressor is reversed by deoxyribose-5-phosphate. Assays for the presence of the cytR and deoR repressors were established by use of S-30 extracts prepared from the regulatory mutants. Dissociation constants for repressor-operator binding as well as for repressor-inducer interactions have been estimated from the results.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204861     DOI: 10.1007/bf00270893

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  19 in total

1.  On the structure of the deo operon of Escherichia coli.

Authors:  P Jorgensen; J Collins; P Valentin-Hansen
Journal:  Mol Gen Genet       Date:  1977-09-21

2.  Relief of polarity in DNA-dependent cell-free synthesis of enzymes of the galactose operon of Escherichia coli.

Authors:  W Wetekam; K Staack; R Ehring
Journal:  Mol Gen Genet       Date:  1972

3.  Mutants constitutive for nucleoside-catabolizing enzymes in Escherichia coli K12. Isolation, charactrization and mapping.

Authors:  A Munch-Petersen; P Nygaard; K Hammer-Jespersen; N Fiil
Journal:  Eur J Biochem       Date:  1972-05-23

4.  DNA-dependent in vitro synthesis of enzymes of the galactose operon of Escherichia coli.

Authors:  W Wetekam; K Staack; R Ehring
Journal:  Mol Gen Genet       Date:  1971

5.  Induction of enzymes involed in the catabolism of deoxyribonucleosides and ribonucleosides in Escherichia coli K 12.

Authors:  K Hammer-Jespersen; A Munch-Petersen; M Schwartz; P Nygaard
Journal:  Eur J Biochem       Date:  1971-04-30

6.  A regulatory mutant affecting the synthesis of enzymes involved in the catabolism of nucleosides in Escherichia coli.

Authors:  S I Ahmad; R H Pritchard
Journal:  Mol Gen Genet       Date:  1971

7.  On the catabolism of deoxyribonucleosides in cells and cell extracts of Escherichia coli.

Authors:  A Munch-Petersen
Journal:  Eur J Biochem       Date:  1968-11

8.  Multiple regulation of nucleoside catabolizing enzymes: effects of a polar dra mutation on the deo enzymes.

Authors:  H Albrechtsen; K Hammer-Jespersen; A Munch-Petersen; N Fiil
Journal:  Mol Gen Genet       Date:  1976-07-23

9.  Genetic analysis of thymidine-resistant and low-thymine-requiring mutants of Escherichia coli K-12 induced by bacteriophage Mu-1.

Authors:  R S Buxton
Journal:  J Bacteriol       Date:  1975-02       Impact factor: 3.490

10.  Regulation by N gene protein of phage lambda of anthranilate synthetase synthesis in vitro.

Authors:  R P Dottin; M L Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

View more
  35 in total

1.  Escherichia coli phnN, encoding ribose 1,5-bisphosphokinase activity (phosphoribosyl diphosphate forming): dual role in phosphonate degradation and NAD biosynthesis pathways.

Authors:  Bjarne Hove-Jensen; Tina J Rosenkrantz; Andreas Haldimann; Barry L Wanner
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

2.  Restored DNA-binding of the cAMP-CRP activator complex reestablishes negative regulation by the CytR repressor in the deoP2 promoter in Escherichia coli.

Authors:  L Søgaard-Andersen; P Valentin-Hansen
Journal:  Mol Gen Genet       Date:  1991-12

3.  Single amino acid substitutions in the cAMP receptor protein specifically abolish regulation by the CytR repressor in Escherichia coli.

Authors:  L Søgaard-Andersen; A S Mironov; H Pedersen; V V Sukhodelets; P Valentin-Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Aerobic growth at nanomolar oxygen concentrations.

Authors:  Daniel A Stolper; Niels Peter Revsbech; Donald E Canfield
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

5.  On the structure of the deo operon of Escherichia coli.

Authors:  P Jorgensen; J Collins; P Valentin-Hansen
Journal:  Mol Gen Genet       Date:  1977-09-21

6.  How to achieve constitutive expression of a gene within an inducible operon: the example of the nagC gene of Escherichia coli.

Authors:  J Plumbridge
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

7.  Photocleavage of DNA and photofootprinting of E. coli RNA polymerase bound to promoter DNA by azido-9-acridinylamines.

Authors:  C Jeppesen; O Buchardt; U Henriksen; P E Nielsen
Journal:  Nucleic Acids Res       Date:  1988-07-11       Impact factor: 16.971

8.  An Hfq-like protein in archaea: crystal structure and functional characterization of the Sm protein from Methanococcus jannaschii.

Authors:  Jesper S Nielsen; Andreas Bøggild; Christian B F Andersen; Gorm Nielsen; Anders Boysen; Ditlev E Brodersen; Poul Valentin-Hansen
Journal:  RNA       Date:  2007-10-24       Impact factor: 4.942

9.  The internal regulated promoter of the deo operon of Escherichia coli K-12.

Authors:  P Valentin-Hansen; K Hammer; J E Løve Larsen; I Svendsen
Journal:  Nucleic Acids Res       Date:  1984-07-11       Impact factor: 16.971

10.  Defining a role for Hfq in Gram-positive bacteria: evidence for Hfq-dependent antisense regulation in Listeria monocytogenes.

Authors:  Jesper Sejrup Nielsen; Lisbeth Kristensen Lei; Tine Ebersbach; Anders Steno Olsen; Janne Kudsk Klitgaard; Poul Valentin-Hansen; Birgitte Haahr Kallipolitis
Journal:  Nucleic Acids Res       Date:  2009-11-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.